glp-1 small molecule agonist A novel approach to exploit Small-Molecule glucagon-like Peptide-1 receptor agonists with high potency Potential oral small-molecule GLP-1R agonist.

Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a case report

Sclerostin regulation, microarchitecture, and advanced glycation end-products in the bone of elderly women with type 2 diabetes

Conduct a baseline nutrition assessment to identify potential risks and create a strong foundation for care

[DOI] [PMC free article] [PubMed] [Google Scholar] 425.Jazayeri A., Rappas M., Brown A.J.H., Kean J., Errey J.C., Robertson N.J

Drug regimen simplicity is an important clinical consideration, particularly in patients receiving multiple medications for the treatment of T2DM and related comorbidities